NCT01950234View on ClinicalTrials.gov

ACTH in Progressive Forms of MS

PHASE2TerminatedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 17, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
Interventions
DRUG

ACTH

Acthar gel

DRUG

Placebo

Placebo

Trial Locations (3)

53215

Wheaton Franciscan Healthcare - St Francis Center for Neurological Disorders, Milwaukee

55414

Clinical Neuroscience Research Unit, University of Minnesota, Minneapolis

58103

Sanford Clinic Neuroscience, Fargo

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

University of Minnesota

OTHER

NCT01950234 - ACTH in Progressive Forms of MS | Biotech Hunter | Biotech Hunter